AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33964140 — intervention group
Group type: COMPARATOR
Intervention: Genetically elevated HDL cholesterol
Number of subjects: 111984
Study 33274867 — intervention group
Group type: EXPERIMENTAL
Intervention: Poultry manure (8 t ha-1) + Gigaspora gigantea inoculation
Number of subjects: 20
Study 33274867 — intervention group
Group type: EXPERIMENTAL
Intervention: Poultry manure (12 t ha-1) + Glomus clarum inoculation
Number of subjects: 20
Study 33274867 — intervention group
Group type: EXPERIMENTAL
Intervention: Sole applications of poultry manure and AMF inoculums
Number of subjects: 20
Study 33274867 — intervention group
Group type: COMPARATOR
Intervention: Control (un-inoculated)
Number of subjects: 20
Study 35946167 — intervention group
Group type: EXPERIMENTAL
Intervention: DIALOG+
Number of subjects: 468
Study 35946167 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 468
Study 32623628 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC) for 60 seconds
Number of subjects: 0
Study 32623628 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC)
Number of subjects: 0
Study 34273647 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat (AME and AMEn)
Number of subjects: 6
Study 34273647 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorghum (AME and AMEn)
Number of subjects: 6
Study 34273647 — intervention group
Group type: EXPERIMENTAL
Intervention: Barley (AME and AMEn)
Number of subjects: 6
Study 34273647 — intervention group
Group type: EXPERIMENTAL
Intervention: Corn (AME and AMEn)
Number of subjects: 6
Study 32686050 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 45
Study 32686050 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 45
Study 35877164 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Prompt App (SPA)
Number of subjects: 116
Study 35877164 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 116
Study 33818134 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Pokémon Go
Number of subjects: 20
Study 33818134 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Pokémon Go
Number of subjects: 20
Study 33818134 — intervention group
Group type: COMPARATOR
Intervention: Traditional walking
Number of subjects: 20
Study 33194976 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspirational lecture
Number of subjects: 0
Study 35162507 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week aerobic and resistance exercise group (EG)
Number of subjects: 30
Study 35162507 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 30
Study 35162507 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (EG and CG)
Number of subjects: 30
Study 33462450 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab (10 mg kg‐1 every 2 weeks)
Number of subjects: 199
Study 33462450 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab
Number of subjects: 199
Study 33462450 — intervention group
Group type: COMPARATOR
Intervention: Maintenance chemotherapy
Number of subjects: 199
Study 33007918 — intervention group
Group type: EXPERIMENTAL
Intervention: Starting Intervention (SI)
Number of subjects: 30
Study 33007918 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups together
Number of subjects: 30
Study 33007918 — intervention group
Group type: COMPARATOR
Intervention: Waiting List Control (WL)
Number of subjects: 30
Study 34238838 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep sedation (MOAA/S 0 to 1)
Number of subjects: 431
Study 32706852 — intervention group
Group type: EXPERIMENTAL
Intervention: FAMS (Family-focused Add-on to Motivate Self-care)
Number of subjects: 0
Study 32706852 — intervention group
Group type: COMPARATOR
Intervention: Individualized text messaging intervention
Number of subjects: 0
Study 32706852 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment as usual (control)
Number of subjects: 0
Study 32497217 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal glucose infusion
Number of subjects: 20
Study 32497217 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal glucose infusion
Number of subjects: 20
Study 33432387 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D imaging
Number of subjects: 44
Study 33432387 — intervention group
Group type: COMPARATOR
Intervention: Non-3D imaging
Number of subjects: 44
Study 36397362 — intervention group
Group type: EXPERIMENTAL
Intervention: Head acupuncture combined with modern rehabilitation training
Number of subjects: 90
Study 36397362 — intervention group
Group type: COMPARATOR
Intervention: Body acupuncture combined with modern rehabilitation training
Number of subjects: 90
Study 36397362 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Head and Body acupuncture)
Number of subjects: 90
Study 33024271 — intervention group
Group type: EXPERIMENTAL
Intervention: lenvatinib-plus-everolimus
Number of subjects: 40
Study 34171822 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1200 mg b.i.d. for eight weeks
Number of subjects: 114
Study 34171822 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 34082190 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Roller (FR)
Number of subjects: 7
Study 34082190 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration Foam Roller (VFR)
Number of subjects: 7
Study 34082190 — intervention group
Group type: COMPARATOR
Intervention: Passive Recovery (PR)
Number of subjects: 7
Study 32769647 — intervention group
Group type: EXPERIMENTAL
Intervention: Midurethral sling and behavioral and pelvic floor muscle therapy (combined group)
Number of subjects: 403
Study 32769647 — intervention group
Group type: COMPARATOR
Intervention: Midurethral sling alone
Number of subjects: 403
Study 34375164 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncovered metallic stent (uncovered MS)
Number of subjects: 92
Study 34375164 — intervention group
Group type: COMPARATOR
Intervention: Covered metallic stent (covered MS)
Number of subjects: 92
Study 32041588 — intervention group
Group type: EXPERIMENTAL
Intervention: MI self-coding exercise using smartphone recording and a standardized scoring sheet
Number of subjects: 55
Study 32041588 — intervention group
Group type: COMPARATOR
Intervention: Control condition (watching an MI expert perform in a video clip)
Number of subjects: 55
Study 34261911 — intervention group
Group type: EXPERIMENTAL
Intervention: Spleen aminopeptide oral lyophilized powder (SAOLP) 4 mg qd for two cycles
Number of subjects: 0
Study 34261911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34261911 — intervention group
Group type: EXPERIMENTAL
Intervention: Spleen aminopeptide oral lyophilized powder (SAOLP)
Number of subjects: 0
Study 32145280 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) 3 times a week for 8 weeks, with work periods of 4 × 4 minutes at 85%-95% of peak heart rate and 3 minutes of active recovery at 50%-70% of peak heart rate.
Number of subjects: 70
Study 32145280 — intervention group
Group type: COMPARATOR
Intervention: Standard care according to national guidelines.
Number of subjects: 70
Study 32145280 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 70
Study 32145280 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 70
Study 33507574 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (5 mg) administered 24 to 35 weeks after the last denosumab dose
Number of subjects: 53
Study 34565343 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted minimally invasive esophagectomy (RAMIE)
Number of subjects: 218
Study 34565343 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive esophagectomy (MIE)
Number of subjects: 218
Study 35899459 — intervention group
Group type: EXPERIMENTAL
Intervention: GOLDIC therapy
Number of subjects: 90
Study 35899459 — intervention group
Group type: COMPARATOR
Intervention: Epidural steroid injections (dexamethasone)
Number of subjects: 90
Study 35899459 — intervention group
Group type: COMPARATOR
Intervention: Manual therapy
Number of subjects: 90
Study 33762032 — intervention group
Group type: EXPERIMENTAL
Intervention: Early childhood mental health consultation (ECMHC)
Number of subjects: 190
Study 33762032 — intervention group
Group type: COMPARATOR
Intervention: Waitlist-control
Number of subjects: 190
Study 34479593 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Tranexamic Acid (1g TXA IV)
Number of subjects: 93
Study 34479593 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-articular Injection of Tranexamic Acid (1g TXA injected peri-articularly)
Number of subjects: 93
Study 33225963 — intervention group
Group type: COMPARATOR
Intervention: Naltrexone (active control)
Number of subjects: 0
Study 33225963 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (promising AUD pharmacotherapy)
Number of subjects: 0
Study 33225963 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36227836 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the left inferior primary motor cortex for 15 minutes
Number of subjects: 9
Study 36227836 — intervention group
Group type: COMPARATOR
Intervention: Sham group received 30s of stimulation
Number of subjects: 9
Study 33932503 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant T-DM1
Number of subjects: 743
Study 33932503 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab
Number of subjects: 743
Study 32872401 — intervention group
Group type: EXPERIMENTAL
Intervention: HE‐HFD (+50% energy, 65% fat)
Number of subjects: 12
Study 32872401 — intervention group
Group type: COMPARATOR
Intervention: Control diet (36% fat)
Number of subjects: 12
Study 36068705 — intervention group
Group type: EXPERIMENTAL
Intervention: IV sulopenem followed by oral sulopenem etzadroxil/probenecid
Number of subjects: 1392
Study 36068705 — intervention group
Group type: COMPARATOR
Intervention: IV ertapenem followed by oral ciprofloxacin or amoxicillin-clavulanate
Number of subjects: 1392
Study 34866483 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral lifestyle intervention for T2DM prevention
Number of subjects: 42
Study 34866483 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (wait-listed control)
Number of subjects: 42
Study 35340107 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyston® (40–60 units)
Number of subjects: 126
Study 35340107 — intervention group
Group type: COMPARATOR
Intervention: Dysport® (40–60 units)
Number of subjects: 126
Study 33734910 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservative-Free (PF) brimonidine/timolol fixed-combination (BTFC) ophthalmic solution
Number of subjects: 106
Study 33734910 — intervention group
Group type: COMPARATOR
Intervention: Preservative-Containing (PC) brimonidine/timolol fixed-combination (BTFC) ophthalmic solution
Number of subjects: 106
Study 33734910 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PF and PC groups
Number of subjects: 106
Study 33109670 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐TIS app
Number of subjects: 2806
Study 33109670 — intervention group
Group type: COMPARATOR
Intervention: Control (current practices)
Number of subjects: 2806
Study 33109670 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐TIS app (high exposure)
Number of subjects: 2806
Study 33949270 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke Coach
Number of subjects: 126
Study 33949270 — intervention group
Group type: COMPARATOR
Intervention: Memory Training
Number of subjects: 126
Study 34702767 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol vibrating-mesh nebulization through HFNC
Number of subjects: 15
Study 33920626 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary liking and frequency of dietary behaviors
Number of subjects: 58
Study 33920626 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrained eaters (low intakes of high fat/sweets)
Number of subjects: 58
Study 33920626 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvements in liking for a healthy diet
Number of subjects: 58
Study 33920626 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent healthier diet liking and healthier intake
Number of subjects: 58
Study 33920626 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating healthier but not healthier diet liking
Number of subjects: 58
Study 33920626 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in liking and frequency of physical activity
Number of subjects: 58
Study 32720870 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV group; either monotherapy or with lomustine)
Number of subjects: 254
Study 32720870 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV group)
Number of subjects: 254
Study 32720870 — intervention group
Group type: COMPARATOR
Intervention: Non-BEV group (lomustine monotherapy)
Number of subjects: 254
Study 33620021 — intervention group
Group type: EXPERIMENTAL
Intervention: Underwater treadmill gait training
Number of subjects: 22
Study 33620021 — intervention group
Group type: COMPARATOR
Intervention: Overground gait training
Number of subjects: 22
Study 33957720 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood group A
Number of subjects: 39850
Study 33957720 — intervention group
Group type: COMPARATOR
Intervention: Blood group O
Number of subjects: 39850
Study 33957720 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood group B
Number of subjects: 39850
Study 33957720 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood group AB
Number of subjects: 39850
Study 33957720 — intervention group
Group type: COMPARATOR
Intervention: Rh-negative
Number of subjects: 39850
Study 33957720 — intervention group
Group type: EXPERIMENTAL
Intervention: Rh-positive
Number of subjects: 39850
Study 32515412 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral counseling (OR) and the use of an application (App) for smartphones
Number of subjects: 291
Study 32515412 — intervention group
Group type: EXPERIMENTAL
Intervention: OR without the app
Number of subjects: 291
Study 32515412 — intervention group
Group type: EXPERIMENTAL
Intervention: Video (VD) and app
Number of subjects: 291
Study 32515412 — intervention group
Group type: EXPERIMENTAL
Intervention: VD without app
Number of subjects: 291
Study 32515412 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of technology (VD and/or App)
Number of subjects: 291
Study 32515412 — intervention group
Group type: COMPARATOR
Intervention: Non‐use of technology (OR alone)
Number of subjects: 291
Study 35317705 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive minimal changes to both first and second implants over a period of nine months to achieve balanced dynamic ranges.
Number of subjects: 19
Study 35317705 — intervention group
Group type: COMPARATOR
Intervention: Changes to their sequential implant only (Control group).
Number of subjects: 19
Study 34474581 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk-oriented exercise program
Number of subjects: 26
Study 34474581 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercise program
Number of subjects: 26
Study 34043719 — intervention group
Group type: EXPERIMENTAL
Intervention: Brazilian propolis (5 tablets daily, 508.5 mg of propolis)
Number of subjects: 80
Study 34043719 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5 tablets daily)
Number of subjects: 80
Study 32408011 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot adenoidectomy (n=30)
Number of subjects: 58
Study 32408011 — intervention group
Group type: COMPARATOR
Intervention: Cold adenoidectomy (n=28)
Number of subjects: 58
Study 35072714 — intervention group
Group type: EXPERIMENTAL
Intervention: Take a Break (TAB) intervention with gamification and NRT sampling
Number of subjects: 433
Study 35072714 — intervention group
Group type: COMPARATOR
Intervention: NRT sampling only (comparison group)
Number of subjects: 433
Study 33634382 — intervention group
Group type: EXPERIMENTAL
Intervention: Eighteen‐month weight loss intervention
Number of subjects: 278
Study 34253599 — intervention group
Group type: EXPERIMENTAL
Intervention: Community monitoring program with training and incentives for patrolling
Number of subjects: 39
Study 34253599 — intervention group
Group type: COMPARATOR
Intervention: Control group (communities not receiving the program)
Number of subjects: 39
Study 34098821 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week intervention to teach resourcefulness plus routine health education
Number of subjects: 72
Study 34098821 — intervention group
Group type: COMPARATOR
Intervention: Routine health education only
Number of subjects: 72
Study 33012589 — intervention group
Group type: EXPERIMENTAL
Intervention: WhisperFlow CPAP
Number of subjects: 140
Study 33012589 — intervention group
Group type: COMPARATOR
Intervention: High Flow Nasal Cannula (HFNC)
Number of subjects: 140
Study 36383473 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 343
Study 36383473 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality
Number of subjects: 343
Study 36383473 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 343
Study 34018919 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP-SD plus usual care
Number of subjects: 300
Study 34018919 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 300
Study 35917763 — intervention group
Group type: EXPERIMENTAL
Intervention: ST+ABR (cognitive-behavioral therapy for smoking cessation and approach bias retraining)
Number of subjects: 96
Study 35917763 — intervention group
Group type: COMPARATOR
Intervention: ST+Sham (cognitive-behavioral therapy for smoking cessation and sham retraining)
Number of subjects: 96
Study 35917763 — intervention group
Group type: EXPERIMENTAL
Intervention: ST+ABR
Number of subjects: 96
Study 35917763 — intervention group
Group type: COMPARATOR
Intervention: ST+Sham
Number of subjects: 96
Study 34280516 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically-predicted IL-6
Number of subjects: 0
Study 34280516 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically-predicted sIL-2Rα
Number of subjects: 0
Study 34280516 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically-predicted IL-9
Number of subjects: 0
Study 34280516 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically-predicted BDNF
Number of subjects: 0
Study 34280516 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically-predicted MCP-1
Number of subjects: 0
Study 34280516 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP
Number of subjects: 0
Study 34280516 — intervention group
Group type: COMPARATOR
Intervention: Bipolar disorder
Number of subjects: 0
Study 36335478 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate VA-ECMO
Number of subjects: 117
Study 36335478 — intervention group
Group type: COMPARATOR
Intervention: No immediate VA-ECMO
Number of subjects: 117
Study 34013615 — intervention group
Group type: EXPERIMENTAL
Intervention: Green-light laser en bloc resection
Number of subjects: 233
Study 34013615 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of bladder tumor
Number of subjects: 233
Study 34013615 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 233
Study 32450182 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin C
Number of subjects: 142
Study 32450182 — intervention group
Group type: COMPARATOR
Intervention: Lactobacillus plantarum and Lactobacillus rhamnosus strains
Number of subjects: 142
Study 32450182 — intervention group
Group type: EXPERIMENTAL
Intervention: PHASTER software
Number of subjects: 142
Study 32450182 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic collinear analysis
Number of subjects: 142
Study 32450182 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus brevis temperate phages
Number of subjects: 142
Study 36111123 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEXL, DEXH)
Number of subjects: 120
Study 36111123 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (REML, REMH)
Number of subjects: 120
Study 36111123 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (PRO)
Number of subjects: 120
Study 32353418 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic assessments of fluid responsiveness (passive leg raise) before fluid bolus or vasopressor increase.
Number of subjects: 124
Study 32353418 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 124
Study 33305896 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine alone
Number of subjects: 0
Study 33305896 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine combined with sildenafil citrate
Number of subjects: 0
Study 33305896 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33114210 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Superoxide Dismutase, Alpha Lipoic Acid, Acetyl L-Carnitine, and Vitamin B12 for 12 months
Number of subjects: 85
Study 33114210 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 85
Study 35802816 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable tracker to monitor the number of steps taken per day
Number of subjects: 51
Study 33893836 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-poling (DP)
Number of subjects: 23
Study 33893836 — intervention group
Group type: COMPARATOR
Intervention: Diagonal-stride (DS)
Number of subjects: 23
Study 36317412 — intervention group
Group type: EXPERIMENTAL
Intervention: Short message to increase self-efficacy via vicarious experiences, verbal persuasion and emotional arousal
Number of subjects: 497
Study 36317412 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no message)
Number of subjects: 497
Study 36317412 — intervention group
Group type: EXPERIMENTAL
Intervention: Short message to increase self-efficacy
Number of subjects: 497
Study 32693993 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal advance care planning (ACP) program
Number of subjects: 200
Study 32693993 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study 32548864 — intervention group
Group type: EXPERIMENTAL
Intervention: N. sativa hydrogel (twice daily for 60 days)
Number of subjects: 60
Study 32548864 — intervention group
Group type: COMPARATOR
Intervention: Placebo hydrogel (twice daily for 60 days)
Number of subjects: 60
Study 615137391 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared service schedule
Number of subjects: 0
Study 615137391 — intervention group
Group type: COMPARATOR
Intervention: Standard 7 days on schedule
Number of subjects: 0